Betta Pharmaceuticals
Oncology-focused pharmaceutical company developing and commercializing targeted small-molecule therapies.
Therapeutic areas
Selected products and programs
Linked curated drug profiles
Selected active clinical trials
Phase 3 · Recruiting · Non-Small Cell Lung Cancer
A Study of BPI-460372 in Advanced Solid Tumor PatientsPhase 1 · Recruiting · Advanced Solid Tumor
A Phase 1 Study of BPI-371153 in Subjects with Advanced Solid Tumors or Relapsed/Refractory LymphomaPhase 1 · Recruiting · Advanced Solid Tumor
Drug-Drug Interaction Study of Vorolanib Tablets in Healthy ParticipantsPhase 1 · Recruiting · DDI (Drug-Drug Interaction)
Real World Study of Icotinib in Adjuvant Post Surgical Treatment for Stage IA2 High Risk to IB EGFR Mutant Non Small Cell Lung CancerNA · Recruiting · NSCLC (Non-small Cell Lung Cancer)
Drug-Drug Interaction Study of Befotertinib Capsules in Healthy Participants.Phase 1 · Recruiting · DDI (Drug-Drug Interaction)
Selected patent records
Primary and company sources
Company and pipeline information can change. Verify material decisions against the linked primary sources.
Evidence & limits
Source: Open the source record
- Record identifier
- /companies/betta-pharmaceuticals/
- Event / action date
- Not separately retained
- Source update date
- Not separately retained
- Platform retrieval / processing date
- Not separately retained
What it supports. Connections found through the catalog, identifiers, or name and alias matching, with source links where retained.
Limits. A company association is not proof of ownership or sponsorship of every linked record. Product, substance, parent-company, and subsidiary relationships may differ.
Connection basis. Catalog, identifier, or normalized name association. Product and company connections are research leads, not ownership determinations.